Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cytisine-based nicotinic partial agonists as novel antidepressant compounds.
Mineur YS, Eibl C, Young G, Kochevar C, Papke RL, Gündisch D, Picciotto MR.
???displayArticle.abstract???
Nicotine and other nicotinic agents are thought to regulate mood in human subjects and have antidepressant-like properties in animal models. Recent studies have demonstrated that blockade of nicotinic acetylcholine receptors (nAChRs) including those containing the beta2 subunit (beta2(*)), results in antidepressant-like effects. Previous studies have shown that cytisine, a partial agonist at alpha4/beta2(*) nAChRs, and a full agonist at alpha3/beta4(*) and alpha7 nAChRs, has antidepressant-like properties in several rodent models of antidepressant efficacy; however, it is not clear whether more selective partial agonists will also be effective in these models. We tested cytisine and two derivatives, 5-bromo-cytisine (5-Br-Cyt) and 3-(pyridin-3'-yl)-cytisine (3-pyr-Cyt) for their ability to act as a partial agonist of different nAChR subtypes and to show antidepressant-like activity in C57/BL6 mice in the tail suspension, the forced-swim, and the novelty-suppressed feeding tests. 3-pyr-Cyt was a partial agonist with very low efficacy at alpha4/beta2(*) nAChRS but had no agonist effects at other nAChRs normally targeted by cytisine, and it was effective in mouse models of antidepressant efficacy. Animals showed dose-dependent antidepressant-like effects in all three behavioral paradigms. 5-Br-Cyt was not effective in behavioral tests when administered peripherally, probably because of its inability to penetrate the blood-brain barrier, because it efficiently reduced immobility in the tail suspension test when administered intraventricularly. These results suggest that novel nicotinic partial agonists may provide new possibilities for development of drugs to treat mood disorders.
Bermudez,
Phosphorylation and function of alpha4beta2 receptor.
2006, Pubmed,
Xenbase
Bermudez,
Phosphorylation and function of alpha4beta2 receptor.
2006,
Pubmed
,
Xenbase Caldarone,
Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice.
2003,
Pubmed Caldarone,
High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation.
2004,
Pubmed Coe,
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
2005,
Pubmed Crawley,
Behavioral phenotyping strategies for mutant mice.
2008,
Pubmed Djurić,
Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines.
1999,
Pubmed Dulawa,
Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test.
2005,
Pubmed Etter,
Cytisine for smoking cessation: a literature review and a meta-analysis.
,
Pubmed Fitch,
Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
2005,
Pubmed García-Colunga,
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac).
1997,
Pubmed
,
Xenbase George,
Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study.
2008,
Pubmed Glassman,
Smoking, smoking cessation, and major depression.
1990,
Pubmed Gnädisch,
High affinity binding of [3H]epibatidine to rat brain membranes.
1999,
Pubmed Gohlke,
Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165.
2002,
Pubmed Gotti,
Brain nicotinic acetylcholine receptors: native subtypes and their relevance.
2006,
Pubmed Imming,
Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands.
2001,
Pubmed Janowsky,
A cholinergic-adrenergic hypothesis of mania and depression.
1972,
Pubmed Jo,
Nicotinic receptor-mediated effects on appetite and food intake.
2002,
Pubmed Mineur,
Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice.
2007,
Pubmed Mineur,
Functional implications of decreases in neurogenesis following chronic mild stress in mice.
2007,
Pubmed Mineur,
Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice.
2006,
Pubmed Mineur,
Antidepressant-like effects of ceftriaxone in male C57BL/6J mice.
2007,
Pubmed Mukhin,
5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors.
2000,
Pubmed Papke,
Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.
2002,
Pubmed
,
Xenbase Papke,
The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery.
2007,
Pubmed
,
Xenbase Papke,
Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.
1994,
Pubmed
,
Xenbase Picciotto,
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain.
1995,
Pubmed Picciotto,
Effect of nicotine and nicotinic receptors on anxiety and depression.
2002,
Pubmed Picciotto,
It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood.
2008,
Pubmed Quick,
Desensitization of neuronal nicotinic receptors.
2002,
Pubmed Rabenstein,
The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice.
2006,
Pubmed Reitstetter,
Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure.
1999,
Pubmed Salas,
Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor.
2003,
Pubmed Salín-Pascual,
Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients.
1995,
Pubmed Semba,
Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats.
1998,
Pubmed Tizabi,
Antidepressant effects of nicotine in an animal model of depression.
1999,
Pubmed Tritto,
Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia.
2004,
Pubmed Zhou,
Human alpha4beta2 acetylcholine receptors formed from linked subunits.
2003,
Pubmed
,
Xenbase Zoli,
Identification of four classes of brain nicotinic receptors using beta2 mutant mice.
1998,
Pubmed
